Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URIROX-1: Reloxaliase in Enteric Hyperoxaluria
NCT03456830Phase 3Completed
- Sponsor
- Allena Pharmaceuticals, Inc.
- Start
- May 2018
- Primary completion
- Sep 2019
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of reloxaliase in enteric hyperoxaluria (EH), sponsored by Allena Pharmaceuticals, Inc.. Started May 2018; status: completed.
02
Drugs
reloxaliase
03
Conditions
enteric hyperoxaluria (EH)
Beyond the preview
Go deeper on NCT03456830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03456830.